User profiles for Ismaheel O. Lawal
 | Ismaheel LawalEmory University Verified email at emory.edu Cited by 1765 |
Predictors of overall and disease-free survival in metastatic castration-resistant prostate cancer patients receiving 225Ac-PSMA-617 radioligand therapy
Metastatic prostate carcinoma overexpresses prostate-specific membrane antigen (PSMA),
making this antigen a suitable target for radioligand therapy of the disease. Here we report …
making this antigen a suitable target for radioligand therapy of the disease. Here we report …
68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli?
T Lengana, IO Lawal, TG Boshomane… - Clinical genitourinary …, 2018 - Elsevier
Purpose 68 Ga ligands targeting prostate-specific membrane antigen (PSMA) are rapidly
emerging as a significant step forward in the management of prostate cancer. PSMA is a type II …
emerging as a significant step forward in the management of prostate cancer. PSMA is a type II …
mCRPC patients receiving 225Ac-PSMA-617 therapy in the post–androgen deprivation therapy setting: response to treatment and survival analysis
225 Ac-PSMA-617, targeting the prostate-specific membrane antigen (PSMA), which is
overexpressed on prostate cancer cells, has shown a remarkable therapeutic efficacy in heavily …
overexpressed on prostate cancer cells, has shown a remarkable therapeutic efficacy in heavily …
Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate …
Purpose Actinium-225-labeled prostate-specific membrane antigen ([ 225 Ac]Ac-PSMA-617)
is safe and effective in the treatment of metastatic castration-resistant prostate cancer (…
is safe and effective in the treatment of metastatic castration-resistant prostate cancer (…
[HTML][HTML] Global experience with PSMA-based alpha therapy in prostate cancer
Purpose This review discusses the current state of prostate-specific membrane antigen (PSMA)-based
alpha therapy of metastatic castration-resistant prostate cancer (mCRPC). With …
alpha therapy of metastatic castration-resistant prostate cancer (mCRPC). With …
Diagnostic sensitivity of Tc‐99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga‐68 PSMA PET/CT
Background Emerging data from published studies are demonstrating the superiority of Ga‐68
PSMA PET/CT imaging in prostate cancer. However, the low yield of the Ge‐68/Ga‐68 …
PSMA PET/CT imaging in prostate cancer. However, the low yield of the Ge‐68/Ga‐68 …
[HTML][HTML] Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV …
Severe acute respiratory coronavirus-2 (SARS-Co-2) is the causative agent of coronavirus
disease-2019 (COVID-19). COVID-19 is a disease with highly variable phenotypes, being …
disease-2019 (COVID-19). COVID-19 is a disease with highly variable phenotypes, being …
Imaging of invasive fungal infections-the role of PET/CT
AO Ankrah, IO Lawal, RAJO Dierckx… - Seminars in nuclear …, 2023 - Elsevier
Over the last decades, the population at risk for invasive fungal disease (IFD) has increased
because of medical therapy advances and diseases compromising patients' immune …
because of medical therapy advances and diseases compromising patients' immune …
[HTML][HTML] 225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings
Purpose 225 Ac-PSMA-617 has demonstrated good anti-tumor effect as a treatment option
for metastatic castration-resistant prostate cancer (mCRPC) patients. No study has previously …
for metastatic castration-resistant prostate cancer (mCRPC) patients. No study has previously …
A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide …
IO Lawal, KMG Mokoala, J Mahapane… - European Journal of …, 2021 - Springer
Purpose Prostate cancer (PCa) commonly metastasizes to the bones. There are several
radionuclide techniques for imaging PCa skeletal metastases. We aimed to compare the lesion …
radionuclide techniques for imaging PCa skeletal metastases. We aimed to compare the lesion …